HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome.

Abstract
Laron syndrome (LS) is a unique model of congenital IGF-I deficiency. It is characterized by dwarfism and obesity, and is caused by deletion or mutations of the growth hormone receptor (GH-R) gene. It is hypothesized that LS is an old disease originating in Indonesia and that the mutated gene spread to South Asia, the Middle East, the Mediterranean region and South America.
AuthorsZvi Laron, Rivka Kauli, Lena Lapkina, Haim Werner
JournalMutation research. Reviews in mutation research (Mutat Res Rev Mutat Res) 2017 Apr - Jun Vol. 772 Pg. 123-133 ISSN: 1388-2139 [Electronic] Netherlands
PMID28528685 (Publication Type: Journal Article, Review, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2016 Elsevier B.V. All rights reserved.
Chemical References
  • Receptors, Somatotropin
  • Insulin-Like Growth Factor I
Topics
  • Adolescent
  • Adult
  • Child
  • Cohort Studies
  • Exons
  • Female
  • Gene Deletion
  • Humans
  • Insulin-Like Growth Factor I (deficiency, genetics, pharmacology)
  • Israel
  • Laron Syndrome (complications, genetics)
  • Longevity
  • Male
  • Middle Aged
  • Mutation
  • Neoplasms (genetics)
  • Obesity (complications, genetics)
  • Pedigree
  • Receptors, Somatotropin (genetics, metabolism)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: